Jorge E Cortes (Jorge Cortes)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 110

Top Venues

Leukemia

American journal of hematology

Leukemia & lymphoma

Blood

This page only lists publications with an associated author ORCID identifier.

Publications

Jorge E Cortes, Elisabetta Abruzzese, Elyce H Cardonick, Sonia Hernandez-Diaz, Jamie Gutierrez, Mary Sullivan Sardegna, Erica Torres-Chavez, Miriam Dinatale, Catherine C Lerro, Brenda J Gehrke, Stacy S Shord, R Angelo de Claro, Marc R Theoret, Peter Joseph DeMaria, Kelly J Norsworthy
Perspectives on drug development for the treatment of chronic myeloid leukemia in pregnant patients and patients who are breastfeeding. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Jorge E Cortes, Koiji Sasaki, Dong-Wook Kim, Timothy P Hughes, Gabriel Etienne, Michael J Mauro, Andreas Hochhaus, Fabian Lang, Michael C Heinrich, Massimo Breccia, Michael W Deininger, Yeow Tee Goh, Jeroen J W M Janssen, Moshe Talpaz, Valle Gomez Garcia de Soria, Philipp le Coutre, Daniel J DeAngelo, Andrea Damon, Silvia Cacciatore, Fotis Polydoros, Nithya Agrawal, Delphine Rea
Asciminib monotherapy in patients with chronic-phase chronic myeloid leukemia with the T315I mutation after ≥1 prior tyrosine kinase inhibitor: 2-year follow-up results. Leukemia 38 (7) (2024)
Elias J Jabbour, Jane F Apperley, Jorge E Cortes, Delphine Rea, Michael W Deininger, Elisabetta Abruzzese, Charles Chuah, Daniel J DeAngelo, Andreas Hochhaus, Jeffrey H Lipton, Michael J Mauro, Franck Nicolini, Javier Pinilla-Ibarz, Gianantonio Rosti, Philippe Rousselot, Neil P Shah, Moshe Talpaz, Alexander Vorog, Xiaowei Ren, Hagop M Kantarjian
Dose modification dynamics of ponatinib in patients with chronic-phase chronic myeloid leukemia (CP-CML) from the PACE and OPTIC trials. Leukemia (2024)
Jorge E Cortes, Brian A Jonas, Gary Schiller, Alice Mims, Gail J Roboz, Andrew H Wei, Pau Montesinos, P Brent Ferrell, Karen Wl Yee, Pierre Fenaux, Anthony Schwarer, Justin M Watts
Olutasidenib in post-venetoclax patients with mutant isocitrate dehydrogenase 1 (m IDH1 ) acute myeloid leukemia (AML). Leukemia & lymphoma 65 (8) (2024)
Kendra L Sweet, Jorge E Cortes, Jane F Apperley, Mel Mann, Michael J Mauro, Vivian G Oehler, Cristina Ruiz, Charles A Schiffer, Lori A Ehrlich, Gulsum E Pamuk, Joseph Wynne, Gautam U Mehta, Olanrewaju O Okusanya, R Angelo de Claro, Marc R Theoret, B Douglas Smith, Kelly J Norsworthy
Project Confirm: Accelerated Drug Approvals for CML-Response. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (1) (2024)
Jorge E Cortes, Koiji Sasaki, Dong-Wook Kim, Timothy P Hughes, Gabriel Etienne, Michael J Mauro, Andreas Hochhaus, Fabian Lang, Michael C Heinrich, Massimo Breccia, Michael W Deininger, Yeow Tee Goh, Jeroen J W M Janssen, Moshe Talpaz, Valle Gomez Garcia de Soria, Philipp le Coutre, Daniel J DeAngelo, Andrea Damon, Silvia Cacciatore, Fotis Polydoros, Nithya Agrawal, Delphine Rea
Asciminib monotherapy in patients with chronic-phase chronic myeloid leukemia with the T315I mutation after ≥1 prior tyrosine kinase inhibitor: 2-year follow-up results. Leukemia 38 (7) (2024)
Lukas Veltmaat, Jorge E Cortes
Arterio-Occlusive Events Among Patients with Chronic Myeloid Leukemia on Tyrosine Kinase Inhibitors. Blood (2024)
Elias J Jabbour, Jane F Apperley, Jorge E Cortes, Delphine Rea, Michael W Deininger, Elisabetta Abruzzese, Charles Chuah, Daniel J DeAngelo, Andreas Hochhaus, Jeffrey H Lipton, Michael J Mauro, Franck Nicolini, Javier Pinilla-Ibarz, Gianantonio Rosti, Philippe Rousselot, Neil P Shah, Moshe Talpaz, Alexander Vorog, Xiaowei Ren, Hagop M Kantarjian
Dose modification dynamics of ponatinib in patients with chronic-phase chronic myeloid leukemia (CP-CML) from the PACE and OPTIC trials. Leukemia 38 (3) (2024)
Andrés Gómez-De León, Andrés Noyola-Pérez, Lourdes Gil-Flores, Hemant Malhotra, Vasile Musteata, Amal Mohamed El-Beshlawy, Hilman Tadjoedin, Carolina Pavlovsky, Jorge E Cortes
Bringing global hematology research to the forefront. Blood advances 8 (14) (2024)
Ana Carolina Mourão Toreli, Marisol M Galvis, Muhannad Sharara, Marcelo Addas-Carvalho, Eliana C M Miranda, Leonardo Fechio, Adriana Silva Santos Duarte, Audrey Basso, Gislaine Duarte, Samuel Souza Medina, Fernando Pericole, Bruno Deltreggia Benites, Kimya Jones, Harmanpreet Singh, Jaspreet Farmaha, Ashutosh Vashisht, Ravindra Kolhe, Ashis K Mondal, Sara Teresinha Olalla Saad, Carmino Antonio de Souza, Jorge E Cortes, Katia B B Pagnano
Exploring SARS-CoV-2 infection and vaccine-induced immunity in chronic myeloid leukemia patients: insights from real-world data in Brazil and the United States. Leukemia & lymphoma (2024)
Omar Mohamed Makram, Tochukwu M Okwuosa, Daniel Addison, Jorge E Cortes, Susan F Dent, Malcolm S Bevel, Sarju Ganatra, Sadeer G Al-Kindi, Catherine C Hedrick, Neal L Weintraub, Xiaoling Wang, Avirup Guha
Cardiovascular Diseases Increase Cancer Mortality in Adults: NHANES-Continuous Study. Journal of the American Heart Association (2024)
Ana Carolina Mourão Toreli, Marisol M Galvis, Muhannad Sharara, Marcelo Addas-Carvalho, Eliana C M Miranda, Leonardo Fechio, Adriana Silva Santos Duarte, Andrea Basso, Gislaine Duarte, Samuel Souza Medina, Fernando Pericole, Bruno Deltreggia Benites, Kimya Jones, Harmanpreet Singh, Jaspreet Farmaha, Ashutosh Vashisht, Ravindra Kolhe, Ashis K Mondal, Sara Teresinha Olalla Saad, Carmino Antonio de Souza, Jorge E Cortes, Katia B B Pagnano
Exploring SARS-CoV-2 infection and vaccine-induced immunity in chronic myeloid leukemia patients: insights from real-world data in Brazil and the United States. Leukemia & lymphoma (2024)
Meng-Han Tsai, Steven Scott Coughlin, Jorge E Cortes
County-level colorectal cancer screening rates on colorectal cancer survival in the state of Georgia: Does county-level rurality matter? Cancer medicine (2024)
Jorge E Cortes, Koiji Sasaki, Dong-Wook Kim, Timothy P Hughes, Gabriel Etienne, Michael J Mauro, Andreas Hochhaus, Fabian Lang, Michael C Heinrich, Massimo Breccia, Michael W Deininger, Yeow Tee Goh, Jeroen J W M Janssen, Moshe Talpaz, Valle Gomez Garcia de Soria, Philipp le Coutre, Daniel J DeAngelo, Andrea Damon, Silvia Cacciatore, Fotis Polydoros, Nithya Agrawal, Delphine Rea
Asciminib monotherapy in patients with chronic-phase chronic myeloid leukemia with the T315I mutation after ≥1 prior tyrosine kinase inhibitor: 2-year follow-up results. Leukemia 38 (7) (2024)
Andrés Gómez-De León, Andrés Noyola-Pérez, Lourdes Gil-Flores, Hemant Malhotra, Vasile Musteata, Amal Mohamed El-Beshlawy, Hilman Tadjoedin, Carolina Pavlovsky, Jorge E Cortes
Bringing global hematology research to the forefront. Blood advances 8 (14) (2024)
Meng-Han Tsai, Steven Scott Coughlin, Jorge E Cortes
County-level colorectal cancer screening rates on colorectal cancer survival in the state of Georgia: Does county-level rurality matter? Cancer medicine 13 (1) (2024)
Jorge E Cortes, Brian A Jonas, Gary Schiller, Alice Mims, Gail J Roboz, Andrew H Wei, Pau Montesinos, P Brent Ferrell, Karen Wl Yee, Pierre Fenaux, Anthony Schwarer, Justin M Watts
Olutasidenib in post-venetoclax patients with mutant isocitrate dehydrogenase 1 (m IDH1 ) acute myeloid leukemia (AML). Leukemia & lymphoma (2024)
Meng-Han Tsai, Steven Scott Coughlin, Jorge E Cortes
County-level colorectal cancer screening rates on colorectal cancer survival in the state of Georgia: Does county-level rurality matter? Cancer medicine (2024)
Mycal Casey, Lorriane Odhiambo, Nidhi Aggarwal, Mahran Shoukier, K M Islam, Jorge E Cortes
Global Trial Representation and Availability of Tyrosine Kinase Inhibitors for Treatment of Chronic Myeloid Leukemia. Cancers 16 (16) (2024)
Mycal Casey, Lorriane Odhiambo, Nidhi Aggarwal, Mahran Shoukier, K M Islam, Jorge E Cortes
Global Trial Representation and Availability of Tyrosine Kinase Inhibitors for Treatment of Chronic Myeloid Leukemia. Cancers 16 (16) (2024)
Lukas Veltmaat, Jorge E Cortes
Arterio-Occlusive Events Among Patients with Chronic Myeloid Leukemia on Tyrosine Kinase Inhibitors. Blood (2024)
Elias J Jabbour, Jane F Apperley, Jorge E Cortes, Delphine Rea, Michael W Deininger, Elisabetta Abruzzese, Charles Chuah, Daniel J DeAngelo, Andreas Hochhaus, Jeffrey H Lipton, Michael J Mauro, Franck Nicolini, Javier Pinilla-Ibarz, Gianantonio Rosti, Philippe Rousselot, Neil P Shah, Moshe Talpaz, Alexander Vorog, Xiaowei Ren, Hagop M Kantarjian
Dose modification dynamics of ponatinib in patients with chronic-phase chronic myeloid leukemia (CP-CML) from the PACE and OPTIC trials. Leukemia 38 (3) (2024)
Jorge E Cortes, Brian A Jonas, Gary Schiller, Alice Mims, Gail J Roboz, Andrew H Wei, Pau Montesinos, P Brent Ferrell, Karen Wl Yee, Pierre Fenaux, Anthony Schwarer, Justin M Watts
Olutasidenib in post-venetoclax patients with mutant isocitrate dehydrogenase 1 (m IDH1 ) acute myeloid leukemia (AML). Leukemia & lymphoma 65 (8) (2024)
Elias J Jabbour, Jane F Apperley, Jorge E Cortes, Delphine Rea, Michael W Deininger, Elisabetta Abruzzese, Charles Chuah, Daniel J DeAngelo, Andreas Hochhaus, Jeffrey H Lipton, Michael J Mauro, Franck Nicolini, Javier Pinilla-Ibarz, Gianantonio Rosti, Philippe Rousselot, Neil P Shah, Moshe Talpaz, Alexander Vorog, Xiaowei Ren, Hagop M Kantarjian
Dose modification dynamics of ponatinib in patients with chronic-phase chronic myeloid leukemia (CP-CML) from the PACE and OPTIC trials. Leukemia 38 (3) (2024)
Hagop M Kantarjian, Susan Branford, Massimo Breccia, Jorge E Cortes, Fadi G Haddad, Andreas Hochhaus, Timothy Hughes, Ghayas C Issa, Elias J Jabbour, Franck E Nicolini, Koiji Sasaki, Francois Xavier-Mahon
Are there new relevant therapeutic endpoints in the modern era of the BCR::ABL1 tyrosine kinase inhibitors in chronic myeloid leukemia? Leukemia 38 (5) (2024)
Jorge E Cortes, Elisabetta Abruzzese, Elyce H Cardonick, Sonia Hernandez-Diaz, Jamie Gutierrez, Mary Sullivan Sardegna, Erica Torres-Chavez, Miriam Dinatale, Catherine C Lerro, Brenda J Gehrke, Stacy S Shord, R Angelo de Claro, Marc R Theoret, Peter Joseph DeMaria, Kelly J Norsworthy
Perspectives on Drug Development for the Treatment of Chronic Myeloid Leukemia in Pregnant Patients and Patients Who Are Breastfeeding. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (17) (2024)
Hagop M Kantarjian, Susan Branford, Massimo Breccia, Jorge E Cortes, Fadi G Haddad, Andreas Hochhaus, Timothy Hughes, Ghayas C Issa, Elias J Jabbour, Franck E Nicolini, Koiji Sasaki, Francois Xavier-Mahon
Are there new relevant therapeutic endpoints in the modern era of the BCR::ABL1 tyrosine kinase inhibitors in chronic myeloid leukemia? Leukemia (2024)
Elias J Jabbour, Jane F Apperley, Jorge E Cortes, Delphine Rea, Michael W Deininger, Elisabetta Abruzzese, Charles Chuah, Daniel J DeAngelo, Andreas Hochhaus, Jeffrey H Lipton, Michael J Mauro, Franck Nicolini, Javier Pinilla-Ibarz, Gianantonio Rosti, Philippe Rousselot, Neil P Shah, Moshe Talpaz, Alexander Vorog, Xiaowei Ren, Hagop M Kantarjian
Dose modification dynamics of ponatinib in patients with chronic-phase chronic myeloid leukemia (CP-CML) from the PACE and OPTIC trials. Leukemia 38 (3) (2024)
Meng-Han Tsai, Steven Scott Coughlin, Jorge E Cortes
County-level colorectal cancer screening rates on colorectal cancer survival in the state of Georgia: Does county-level rurality matter? Cancer medicine (2024)
Kendra L Sweet, Jorge E Cortes, Jane F Apperley, Mel Mann, Michael J Mauro, Vivian G Oehler, Cristina Ruiz, Charles A Schiffer, Lori A Ehrlich, Gulsum E Pamuk, Joseph Wynne, Gautam U Mehta, Olanrewaju O Okusanya, R Angelo de Claro, Marc R Theoret, B Douglas Smith, Kelly J Norsworthy
Project Confirm: Accelerated Drug Approvals for CML-Response. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (1) (2024)
Jorge E Cortes, Koiji Sasaki, Dong-Wook Kim, Timothy P Hughes, Gabriel Etienne, Michael J Mauro, Andreas Hochhaus, Fabian Lang, Michael C Heinrich, Massimo Breccia, Michael W Deininger, Yeow Tee Goh, Jeroen J W M Janssen, Moshe Talpaz, Valle Gomez Garcia de Soria, Philipp le Coutre, Daniel J DeAngelo, Andrea Damon, Silvia Cacciatore, Fotis Polydoros, Nithya Agrawal, Delphine Rea
Asciminib monotherapy in patients with chronic-phase chronic myeloid leukemia with the T315I mutation after ≥1 prior tyrosine kinase inhibitor: 2-year follow-up results. Leukemia (2024)
Kendra L Sweet, Jorge E Cortes, Jane F Apperley, Mel Mann, Michael J Mauro, Vivian G Oehler, Cristina Ruiz, Charles A Schiffer, Lori A Ehrlich, Gulsum E Pamuk, Joseph Wynne, Gautam U Mehta, Olanrewaju O Okusanya, R Angelo de Claro, Marc R Theoret, B Douglas Smith, Kelly J Norsworthy
Project Confirm: Accelerated Drug Approvals for CML-Response. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (1) (2024)
Lukas Veltmaat, Jorge E Cortes
Arterio-occlusive events among patients with chronic myeloid leukemia on tyrosine kinase inhibitors. Blood 143 (10) (2024)
Lukas Veltmaat, Jorge E Cortes
Arterio-occlusive events among patients with chronic myeloid leukemia on tyrosine kinase inhibitors. Blood 143 (10) (2024)
Omar Mohamed Makram, Tochukwu M Okwuosa, Daniel Addison, Jorge E Cortes, Susan F Dent, Malcolm S Bevel, Sarju Ganatra, Sadeer G Al-Kindi, Catherine C Hedrick, Neal L Weintraub, Xiaoling Wang, Avirup Guha
Cardiovascular Diseases Increase Cancer Mortality in Adults: NHANES-Continuous Study. Journal of the American Heart Association 13 (15) (2024)
Elias J Jabbour, Jane F Apperley, Jorge E Cortes, Delphine Rea, Michael W Deininger, Elisabetta Abruzzese, Charles Chuah, Daniel J DeAngelo, Andreas Hochhaus, Jeffrey H Lipton, Michael J Mauro, Franck Nicolini, Javier Pinilla-Ibarz, Gianantonio Rosti, Philippe Rousselot, Neil P Shah, Moshe Talpaz, Alexander Vorog, Xiaowei Ren, Hagop M Kantarjian
Dose modification dynamics of ponatinib in patients with chronic-phase chronic myeloid leukemia (CP-CML) from the PACE and OPTIC trials. Leukemia 38 (3) (2024)
Elias J Jabbour, Jane F Apperley, Jorge E Cortes, Delphine Rea, Michael W Deininger, Elisabetta Abruzzese, Charles Chuah, Daniel J DeAngelo, Andreas Hochhaus, Jeffrey H Lipton, Michael J Mauro, Franck Nicolini, Javier Pinilla-Ibarz, Gianantonio Rosti, Philippe Rousselot, Neil P Shah, Moshe Talpaz, Alexander Vorog, Xiaowei Ren, Hagop M Kantarjian
Dose modification dynamics of ponatinib in patients with chronic-phase chronic myeloid leukemia (CP-CML) from the PACE and OPTIC trials. Leukemia 38 (3) (2024)
Andrés Gómez-De León, Andrés Noyola-Pérez, Lourdes Gil-Flores, Hemant Malhotra, Vasile Musteata, Amal Mohamed El-Beshlawy, Hilman Tadjoedin, Carolina Pavlovsky, Jorge E Cortes
Bringing global hematology research to the forefront. Blood advances 8 (14) (2024)
Andrés Gómez-De León, Andres Noyola-Pérez, Lourdes Gil-Flores, Hemant Malhotra, Vasile Musteata, Amal Mohamed El-Beshlawy, Hilman Tadjoedin, Carolina Pavlovsky, Jorge E Cortes
Bringing Global Hematology Research to the Forefront. Blood advances (2024)
Elias J Jabbour, Jane F Apperley, Jorge E Cortes, Delphine Rea, Michael W Deininger, Elisabetta Abruzzese, Charles Chuah, Daniel J DeAngelo, Andreas Hochhaus, Jeffrey H Lipton, Michael J Mauro, Franck Nicolini, Javier Pinilla-Ibarz, Gianantonio Rosti, Philippe Rousselot, Neil P Shah, Moshe Talpaz, Alexander Vorog, Xiaowei Ren, Hagop M Kantarjian
Dose modification dynamics of ponatinib in patients with chronic-phase chronic myeloid leukemia (CP-CML) from the PACE and OPTIC trials. Leukemia 38 (3) (2024)
Jorge E Cortes, Koiji Sasaki, Dong-Wook Kim, Timothy P Hughes, Gabriel Etienne, Michael J Mauro, Andreas Hochhaus, Fabian Lang, Michael C Heinrich, Massimo Breccia, Michael W Deininger, Yeow Tee Goh, Jeroen J W M Janssen, Moshe Talpaz, Valle Gomez Garcia de Soria, Philipp le Coutre, Daniel J DeAngelo, Andrea Damon, Silvia Cacciatore, Fotis Polydoros, Nithya Agrawal, Delphine Rea
Asciminib monotherapy in patients with chronic-phase chronic myeloid leukemia with the T315I mutation after ≥1 prior tyrosine kinase inhibitor: 2-year follow-up results. Leukemia 38 (7) (2024)
Elias J Jabbour, Jane F Apperley, Jorge E Cortes, Delphine Rea, Michael W Deininger, Elisabetta Abruzzese, Charles Chuah, Daniel J DeAngelo, Andreas Hochhaus, Jeffrey H Lipton, Michael J Mauro, Franck Nicolini, Javier Pinilla-Ibarz, Gianantonio Rosti, Philippe Rousselot, Neil P Shah, Moshe Talpaz, Alexander Vorog, Xiaowei Ren, Hagop M Kantarjian
Correction: Dose modification dynamics of ponatinib in patients with chronic-phase chronic myeloid leukemia (CP-CML) from the PACE and OPTIC trials. Leukemia (2024)
Hagop M Kantarjian, Susan Branford, Massimo Breccia, Jorge E Cortes, Fadi G Haddad, Andreas Hochhaus, Timothy Hughes, Ghayas C Issa, Elias J Jabbour, Franck E Nicolini, Koiji Sasaki, Francois Xavier-Mahon
Are there new relevant therapeutic endpoints in the modern era of the BCR::ABL1 tyrosine kinase inhibitors in chronic myeloid leukemia? Leukemia 38 (5) (2024)
Kendra L Sweet, Jorge E Cortes, Jane F Apperley, Mel Mann, Michael J Mauro, Vivian G Oehler, Cristina Ruiz, Charles A Schiffer, Lori A Ehrlich, Gulsum E Pamuk, Joseph Wynne, Gautam U Mehta, Olanrewaju O Okusanya, R Angelo de Claro, Marc R Theoret, B Douglas Smith, Kelly J Norsworthy
Project Confirm: Accelerated Drug Approvals for CML-Response. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (1) (2024)
Andreas Hochhaus, Delphine Réa, Carla Boquimpani, Yosuke Minami, Jorge E Cortes, Timothy P Hughes, Jane F Apperley, Elza Lomaia, Sergey Voloshin, Anna G Turkina, Dong-Wook Kim, Andre Abdo, Laura Maria Fogliatto, Philipp le Coutre, Koiji Sasaki, Dennis Dong Hwan Kim, Susanne Saussele, Mario Annunziata, Naeem Chaudhri, Lynette Chee, J Valentín García-Gutiérrez, Shruti Kapoor, Alex Allepuz, Sara Quenet, Véronique Bédoucha, Michael J Mauro
Asciminib vs bosutinib in chronic-phase chronic myeloid leukemia previously treated with at least two tyrosine kinase inhibitors: longer-term follow-up of ASCEMBL. Leukemia 37 (3) (2023)
Mahesh Swaminathan, Jorge E Cortes
Update on the role of gemtuzumab-ozogamicin in the treatment of acute myeloid leukemia. Therapeutic advances in hematology 14 (2023)
Andreas Hochhaus, Delphine Réa, Carla Boquimpani, Yosuke Minami, Jorge E Cortes, Timothy P Hughes, Jane F Apperley, Elza Lomaia, Sergey Voloshin, Anna G Turkina, Dong-Wook Kim, Andre Abdo, Laura Maria Fogliatto, Philipp le Coutre, Koiji Sasaki, Dennis Dong Hwan Kim, Susanne Saussele, Mario Annunziata, Naeem Chaudhri, Lynette Chee, J Valentín García-Gutiérrez, Shruti Kapoor, Alex Allepuz, Sara Quenet, Véronique Bédoucha, Michael J Mauro
Asciminib vs bosutinib in chronic-phase chronic myeloid leukemia previously treated with at least two tyrosine kinase inhibitors: longer-term follow-up of ASCEMBL. Leukemia 37 (3) (2023)
Stéphane de Botton, Pierre Fenaux, Karen W L Yee, Christian Recher, Andrew H Wei, Pau Montesinos, David C Taussig, Arnaud Pigneux, Thorsten Braun, Antonio Curti, Carolyn S Grove, Brian A Jonas, Asim Khwaja, Ollivier Legrand, Pierre Peterlin, Montserrat Arnan, William Blum, Daniela Cilloni, Devendra K Hiwase, Joseph G Jurcic, Jürgen Krauter, Xavier G Thomas, Justin M Watts, Jay Yang, Olga Polyanskaya, Julie Brevard, Jennifer Sweeney, Emma Barrett, Jorge E Cortes
Olutasidenib (FT-2102) induces durable complete remissions in patients with relapsed or refractory IDH1-mutated AML. Blood advances (2023)
Andreas Hochhaus, Delphine Réa, Carla Boquimpani, Yosuke Minami, Jorge E Cortes, Timothy P Hughes, Jane F Apperley, Elza Lomaia, Sergey Voloshin, Anna G Turkina, Dong-Wook Kim, Andre Abdo, Laura Maria Fogliatto, Philipp le Coutre, Koiji Sasaki, Dennis Dong Hwan Kim, Susanne Saussele, Mario Annunziata, Naeem Chaudhri, Lynette Chee, J Valentín García-Gutiérrez, Shruti Kapoor, Alex Allepuz, Sara Quenet, Véronique Bédoucha, Michael J Mauro
Asciminib vs bosutinib in chronic-phase chronic myeloid leukemia previously treated with at least two tyrosine kinase inhibitors: longer-term follow-up of ASCEMBL. Leukemia 37 (3) (2023)
Mikkael A Sekeres, Pau Montesinos, Jan Novak, Jian-Xiang Wang, Deepa Jeyakumar, Benjamin K Tomlinson, Jiri Mayer, Erin Jou, Tadeusz Robak, David C Taussig, Hervé Dombret, Akil A Merchant, Naveed Shaik, Thomas O'Brien, Whijae Roh, Xueli Liu, Wendy Ma, Christine G DiRienzo, Geoffrey Chan, Jorge E Cortes
Glasdegib plus intensive or non-intensive chemotherapy for untreated acute myeloid leukemia: results from the randomized, phase 3 BRIGHT AML 1019 trial. Leukemia (2023)
May Garrett, Beverly Knight, Jorge E Cortes, Michael W Deininger
Population modeling of bosutinib exposure-response in patients with newly diagnosed chronic phase chronic myeloid leukemia. Cancer medicine (2023)
Andreas Hochhaus, Delphine Réa, Carla Boquimpani, Yosuke Minami, Jorge E Cortes, Timothy P Hughes, Jane F Apperley, Elza Lomaia, Sergey Voloshin, Anna G Turkina, Dong-Wook Kim, Andre Abdo, Laura Maria Fogliatto, Philipp le Coutre, Koiji Sasaki, Dennis Dong Hwan Kim, Susanne Saussele, Mario Annunziata, Naeem Chaudhri, Lynette Chee, J Valentín García-Gutiérrez, Shruti Kapoor, Alex Allepuz, Sara Quenet, Véronique Bédoucha, Michael J Mauro
Asciminib vs bosutinib in chronic-phase chronic myeloid leukemia previously treated with at least two tyrosine kinase inhibitors: longer-term follow-up of ASCEMBL. Leukemia 37 (3) (2023)
Andreas Hochhaus, Delphine Réa, Carla Boquimpani, Yosuke Minami, Jorge E Cortes, Timothy P Hughes, Jane F Apperley, Elza Lomaia, Sergey Voloshin, Anna G Turkina, Dong-Wook Kim, Andre Abdo, Laura Maria Fogliatto, Philipp le Coutre, Koiji Sasaki, Dennis Dong Hwan Kim, Susanne Saussele, Mario Annunziata, Naeem Chaudhri, Lynette Chee, J Valentín García-Gutiérrez, Shruti Kapoor, Alex Allepuz, Sara Quenet, Véronique Bédoucha, Michael J Mauro
Asciminib vs bosutinib in chronic-phase chronic myeloid leukemia previously treated with at least two tyrosine kinase inhibitors: longer-term follow-up of ASCEMBL. Leukemia (2023)
Mycal Casey, Lorriane A Odhiambo, Nidhi Aggarwal, Mahran Shoukier, K M Islam, Jorge E Cortes
Representation of the Population in Need for Pivotal Clinical Trials in Lymphomas. Blood (2023)
Mahesh Swaminathan, Jorge E Cortes
Update on the role of gemtuzumab-ozogamicin in the treatment of acute myeloid leukemia. Therapeutic advances in hematology 14 (2023)
Marisol Miranda Galvis, Kellen Tjioe, Andrew Balas, Gagan Agrawal, Jorge E Cortes
Disparities in Survival of Hematologic Malignancies in the Context of Social Determinants of Health: A Systematic Review. Blood advances (2023)
Ellin Berman, Neil P Shah, Michael W Deininger, Jessica K Altman, Maria Amaya, Kebede H Begna, Ravi Bhatia, Onyee Chan, Robert H Collins, Peter Curtin, Daniel J DeAngelo, Michael W Drazer, Lori Maness, Leland L Metheny, Sanjay Mohan, Joseph Moore, Vivian Oehler, Keith W Pratz, Iskra Pusic, Michal Rose, William Shomali, B Douglas Smith, Michael Styler, Kendra Sweet, Moshe Talpaz, Tiffany Tanaka, Srinivas Tantravahi, Steven Tsai, Jennifer Vaughn, Jeanna Welborn, David Yang, Michael Mauro, Jorge E Cortes, Jerald Radich, Brian J Druker
CML and the WHO: Why? Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Michael J Mauro, Timothy P Hughes, Dong-Wook Kim, Delphine Rea, Jorge E Cortes, Andreas Hochhaus, Koiji Sasaki, Massimo Breccia, Moshe Talpaz, Oliver Ottmann, Hironobu Minami, Yeow Tee Goh, Daniel J DeAngelo, Michael C Heinrich, Valle Gómez-García de Soria, Philipp le Coutre, Francois-Xavier Mahon, Jeroen J W M Janssen, Michael Deininger, Naranie Shanmuganathan, Mark Blaine Geyer, Silvia Cacciatore, Fotis Polydoros, Nithya Agrawal, Matthias Hoch, Fabian Lang
Asciminib monotherapy in patients with CML-CP without BCR::ABL1 T315I mutations treated with at least two prior TKIs: 4-year phase 1 safety and efficacy results. Leukemia (2023)
Tim Henrik Brümmendorf, Jorge E Cortes, Dragana Milojkovic, Carlo B Gambacorti-Passerini, Richard E Clark, Philipp le Coutre, J Valentín García-Gutiérrez, Charles Chuah, Vamsi K Kota, Jeffrey H Lipton, Philippe Rousselot, Michael J Mauro, Andreas Hochhaus, Rafael Hurtado Monroy, Eric Leip, Simon Purcell, Anne Yver, Andrea Viqueira, Michael W Deininger, null null
Bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia: final results from the BFORE trial. Leukemia 36 (7) (2022)
Daniel A Arber, Attilio Orazi, Robert P Hasserjian, Michael J Borowitz, Katherine R Calvo, Hans Michael Kvasnicka, Sa A Wang, Adam Bagg, Tiziano Barbui, Susan Branford, Carlos E Bueso-Ramos, Jorge E Cortes, Paola Dal Cin, Courtney D D DiNardo, Hervé Dombret, Eric J Duncavage, Benjamin L Ebert, Elihu H Estey, Fabio Facchetti, Kathryn Foucar, Naseema Gangat, Umberto Gianelli, Lucy A Godley, Nicola Gökbuget, Jason Gotlib, Eva Hellström-Lindberg, Gabriela S Hobbs, Ronald Hoffman, Elias J Jabbour, Jean-Jacques Kiladjian, Richard A Larson, Michelle M Le Beau, Mignon L-C Loh, Bob Löwenberg, Elizabeth A Macintyre, Luca Malcovati, Charles G Mullighan, Charlotte M Niemeyer, Olatoyosi M Odenike, Seishi Ogawa, Alberto Orfao, Elli Papaemmanuil, Francesco Passamonti, Kimmo Porkka, Ching-Hon Pui, Jerald P Radich, Andreas Reiter, Maria Rozman, Martina Rudelius, Michael R Savona, Charles A Schiffer, Annette Schmitt-Graeff, Akiko Shimamura, Jorge Sierra, Wendy A Stock, Richard M Stone, Martin S Tallman, Jürgen Thiele, Hwei-Fang Tien, Alexandar Tzankov, Alessandro Maria Maria Vannucchi, Paresh Vyas, Andrew H Wei, Olga K Weinberg, Agnieszka Świątek, Mario Cazzola, Hartmut Döhner, Ayalew Tefferi
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data. Blood 140 (11) (2022)
Hagop M Kantarjian, Elias J Jabbour, Michael Deininger, Elisabetta Abruzzese, Jane Apperley, Jorge E Cortes, Charles Chuah, Daniel J DeAngelo, John DiPersio, Andreas Hochhaus, Jeffrey Lipton, Franck E Nicolini, Javier Pinilla-Ibarz, Delphine Rea, Gianantonio Rosti, Philippe Rousselot, Neil P Shah, Moshe Talpaz, Shouryadeep Srivastava, Xiaowei Ren, Michael Mauro
Ponatinib after failure of second-generation tyrosine kinase inhibitor in resistant chronic-phase chronic myeloid leukemia. American journal of hematology 97 (11) (2022)
Jorge E Cortes, Andreas Hochhaus, Naoto Takahashi, Richard A Larson, Ghayas C Issa, Felice Bombaci, Nicholas Ramscar, Sophie Ifrah, Timothy P Hughes
Asciminib monotherapy for newly diagnosed chronic myeloid leukemia in chronic phase: the ASC4FIRST phase III trial. Future oncology (London, England) 18 (38) (2022)
Mycal Casey, Lorriane Odhiambo, Nidhi Aggarwal, Mahran Shoukier, Jamani B Garner, K M Islam, Jorge E Cortes
Are Pivotal Clinical Trials for Drugs Approved for Leukemias and Multiple Myeloma Representative of the Population at Risk? Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (32) (2022)
Jorge E Cortes, Andreas Hochhaus, Naoto Takahashi, Richard A Larson, Ghayas C Issa, Felice Bombaci, Nicholas Ramscar, Sophie Ifrah, Timothy P Hughes
Asciminib monotherapy for newly diagnosed chronic myeloid leukemia in chronic phase: the ASC4FIRST phase III trial. Future oncology (London, England) (2022)
Jorge E Cortes, Andreas Hochhaus, Naoto Takahashi, Richard A Larson, Ghayas C Issa, Felice Bombaci, Nicholas Ramscar, Sophie Ifrah, Timothy P Hughes
Asciminib monotherapy for newly diagnosed chronic myeloid leukemia in chronic phase: the ASC4FIRST phase III trial. Future oncology (London, England) 18 (38) (2022)
Steven Scott Coughlin, Biplab Kumar Datta, Lovoria B Williams, Malcolm S Bevel, Jorge E Cortes
Characteristics of Cancer Survivors Living in Poverty in the United States: Results From the 2020 Behavioral Risk Factor Surveillance System Survey. JCO oncology practice 18 (11) (2022)
Kendra L Sweet, Jorge E Cortes, Jane F Apperley, Mel Mann, Michael J Mauro, Vivian G Oehler, Cristina Ruiz, Charles A Schiffer, Lori A Ehrlich, Gulsum E Pamuk, Joseph Wynne, Gautam U Mehta, R Angelo de Claro, Marc R Theoret, B Douglas Smith, Kelly J Norsworthy
Project Confirm: Accelerated Drug Approvals for Chronic Myeloid Leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Jorge E Cortes, Andreas Hochhaus, Naoto Takahashi, Richard A Larson, Ghayas C Issa, Felice Bombaci, Nicholas Ramscar, Sophie Ifrah, Timothy P Hughes
Asciminib monotherapy for newly diagnosed chronic myeloid leukemia in chronic phase: the ASC4FIRST phase III trial. Future oncology (London, England) 18 (38) (2022)
Fady Gh Haddad, Koiji Sasaki, Ghayas C Issa, Guillermo Garcia Manero, Farhad Ravandi, Tapan Mahendra Kadia, Jorge E Cortes, Marina Y Konopleva, Naveen Pemmaraju, Yesid Alvarado, Musa Ylimaz, Gautam Borthakur, Courtney D D DiNardo, Nitin Jain, Naval G Daver, Nicholas James Short, Elias J Jabbour, Hagop Kantarjian
Treatment-free remission in patients with chronic myeloid leukemia following the discontinuation of tyrosine kinase inhibitors. American journal of hematology 97 (7) (2022)
Steven Scott Coughlin, Jie Chen, Jorge E Cortes
Health care access and utilization among adult cancer survivors: Results from the National Institutes of Health "All of Us" Research Program. Cancer medicine 10 (11) (2021)
Patrick K Reville, Hagop M Kantarjian, Farhad Ravandi, Elias Jabbour, Courtney D D DiNardo, Naval Daver, Naveen Pemmaraju, Maro Ohanian, Yesid Alvarado, Lianchun Xiao, Gheath Alatrash, Sanam Loghavi, Caitlin R Rausch, Gautam Borthakur, Marina Y Konopleva, Jorge E Cortes, Tapan Mahendra Kadia
Nivolumab maintenance in high-risk acute myeloid leukemia patients: a single-arm, open-label, phase II study. Blood cancer journal 11 (3) (2021)
Jorge E Cortes, Fabian Lang
Third-line therapy for chronic myeloid leukemia: current status and future directions. Journal of hematology & oncology 14 (1) (2021)
Mahran Shoukier, Michal Kubiak, Jorge E Cortes
Review of New-Generation Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia. Current oncology reports 23 (8) (2021)
Nitin Jain, Abhishek Maiti, Farhad Ravandi, Marina Y Konopleva, Naval G Daver, Tapan Mahendra Kadia, Naveen Pemmaraju, Nicholas James Short, Partow Kebriaei, Jing Ning, Jorge E Cortes, Elias J Jabbour, Hagop Kantarjian
Inotuzumab ozogamicin with bosutinib for relapsed or refractory Philadelphia chromosome positive acute lymphoblastic leukemia or lymphoid blast phase of chronic myeloid leukemia. American journal of hematology 96 (8) (2021)
Kiyomi Morita, Feng Wang, Katharina Jahn, Tianyuan Hu, Tomoyuki Tanaka, Yuya Sasaki, Jack Kuipers, Sanam Loghavi, Sa A Wang, Yuanqing Yan, Ken Furudate, Jairo Matthews, Latasha Little, Curtis Gumbs, Jianhua Zhang, Xingzhi Song, Erika Thompson, Keyur P Patel, Carlos E Bueso-Ramos, Courtney D D DiNardo, Farhad Ravandi, Elias Jabbour, Michael Andreeff, Jorge E Cortes, Kapil Bhalla, Guillermo Garcia Manero, Hagop Kantarjian, Marina Y Konopleva, Daisuke Nakada, Nicholas Navin, Niko Beerenwinkel, P Andrew Futreal, Koichi Takahashi
Author Correction: Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics. Nature communications 12 (1) (2021)
Jorge E Cortes, Hagop M Kantarjian, Michael J Mauro, Fiona An, Sonja Nick, Eric Leip, Carlo Gambacorti-Passerini, Tim H Brümmendorf
Long-term cardiac, vascular, hypertension, and effusion safety of bosutinib in patients with Philadelphia chromosome-positive leukemia resistant or intolerant to prior therapy. European journal of haematology 106 (6) (2021)
Jorge E Cortes, Tara L Lin, Geoffrey L Uy, Robert J Ryan, Stefan Faderl, Jeffrey E Lancet
Quality-adjusted Time Without Symptoms of disease or Toxicity (Q-TWiST) analysis of CPX-351 versus 7 + 3 in older adults with newly diagnosed high-risk/secondary AML. Journal of hematology & oncology 14 (1) (2021)
Kelly Sharon Chien, Kunhwa Kim, Graciela M Nogueras-Gonzalez, Gautam Borthakur, Kiran Naqvi, Naval G Daver, Guillermo Montalban Bravo, Jorge E Cortes, Courtney D DiNardo, Elias Jabbour, Yesid Alvarado, Michael Andreeff, Prithviraj Bose, Nitin Jain, Tapan M Kadia, Xuelin Huang, Kimberly B Sheppard, Cheri Klingner-Winton, Sherry A Pierce, Xiao Qin Dong, Kelly A Soltysiak, Hagop M Kantarjian, Guillermo Garcia Manero
Phase II study of azacitidine with pembrolizumab in patients with intermediate-1 or higher-risk myelodysplastic syndrome. British journal of haematology 195 (3) (2021)
Jorge E Cortes, Jane F Apperley, Elza Lomaia, Beatriz Moiraghi, Maria Undurraga Sutton, Carolina Pavlovsky, Charles Chuah, Tomasz Sacha, Jeffrey H Lipton, Charles A Schiffer, James McCloskey, Andreas Hochhaus, Philippe Rousselot, Gianantonio Rosti, Hugues de Lavallade, Anna Turkina, Christine Rojas, Christopher Kevin Arthur, Lori Maness, Moshe Talpaz, Michael J Mauro, Tracey Hall, Vickie Lu, Shouryadeep Srivastava, Michael Deininger
Ponatinib dose-ranging study in chronic-phase chronic myeloid leukemia: a randomized, open-label phase 2 clinical trial. Blood 138 (21) (2021)
Jorge E Cortes, Priyanka Mehta
Determination of fitness and therapeutic options in older patients with acute myeloid leukemia. American journal of hematology 96 (4) (2021)
Kiyomi Morita, Feng Wang, Katharina Jahn, Tianyuan Hu, Tomoyuki Tanaka, Yuya Sasaki, Jack Kuipers, Sanam Loghavi, Sa A Wang, Yuanqing Yan, Ken Furudate, Jairo Matthews, Latasha Little, Curtis Gumbs, Jianhua Zhang, Xingzhi Song, Erika Thompson, Keyur P Patel, Carlos E Bueso-Ramos, Courtney D D DiNardo, Farhad Ravandi, Elias Jabbour, Michael Andreeff, Jorge E Cortes, Kapil Bhalla, Guillermo Garcia Manero, Hagop Kantarjian, Marina Y Konopleva, Daisuke Nakada, Nicholas Navin, Niko Beerenwinkel, P Andrew Futreal, Koichi Takahashi
Publisher Correction: Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics. Nature communications 11 (1) (2020)
Catherine Kendall Major, Hagop Kantarjian, Koji Sasaki, Gautam Borthakur, Tapan Kadia, Naveen Pemmaraju, Courtney DiNardo, Nicholas J Short, Naval Daver, Elias Jabbour, Richard Champlin, Guillermo Garcia-Manero, Marina Konopleva, Michael Andreeff, Steven Kornblau, William Wierda, Sherry Pierce, Farhad Ravandi, Jorge E Cortes
Survivorship in AML - a landmark analysis on the outcomes of acute myelogenous leukemia patients after maintaining complete remission for at least 3 years. Leukemia & lymphoma 61 (13) (2020)
Bei Hu, Xiao Lin, Hans C Lee, Xuelin Huang, Rebecca S Slack Tidwell, Kwang Woo Ahn, Zhen-Huan Hu, Elias Jabbour, Srdan Verstovsek, Farhad Ravandi, Guillermo Garcia-Manero, Mohamed A Kharfan-Dabaja, Nasheed M Hossain, David I Marks, Rammuriti T Kamble, Yoshihiro Inamoto, Tamila Kindwall-Keller, Ayman Saad, Mark R Litzow, Bipin N Savani, Gregory A Hale, Ulrike Bacher, Aaron T Gerds, Jane L Liesveld, Celalettin Ustun, Richard F Olsson, Andrew Daly, Michael R Grunwald, Melhem Solh, Zachariah DeFilipp, Mahmoud Aljurf, Baldeep Wirk, Gorgun Akpek, Taiga Nishihori, Jan Cerny, Sachiko Seo, Jack W Hsu, Richard Champlin, Marcos de Lima, Edwin Alyea, Uday Popat, Ronald Sobecks, Bart L Scott, Hagop Kantarjian, Jorge E Cortes, Wael Saber
Timing of allogeneic hematopoietic cell transplantation (alloHCT) for chronic myeloid leukemia (CML) patients. Leukemia & lymphoma 61 (12) (2020)
Yasmin M Abaza, Hagop M Kantarjian, Yasmin Alwash, Gautam Borthakur, Richard Champlin, Tapan Mahendra Kadia, Guillermo Garcia-Manero, Naval G Daver, Farhad Ravandi, Srdan Verstovsek, Jan Burger, Zeev Estrov, Maro Ohanian DO, Miranda Lim, Naveen Pemmaraju, Elias J Jabbour, Jorge E Cortes
Phase I/II study of dasatinib in combination with decitabine in patients with accelerated or blast phase chronic myeloid leukemia. American journal of hematology 95 (11) (2020)
Jorge E Cortes, Florian H Heidel, Walter Fiedler, B Douglas Smith, Tadeusz Robak, Pau Montesinos, Anna Candoni, Brian Leber, Mikkael A Sekeres, Daniel A Pollyea, Roxanne Ferdinand, Weidong Wendy Ma, Thomas O'Brien, Ashleigh O'Connell, Geoffrey Chan, Michael Heuser
Survival outcomes and clinical benefit in patients with acute myeloid leukemia treated with glasdegib and low-dose cytarabine according to response to therapy. Journal of hematology & oncology 13 (1) (2020)
Jorge E Cortes, Marcos de Lima, Hervé Dombret, Elihu H Estey, Sergio A Giralt, Pau Montesinos, Christoph Röllig, Adriano Venditti, Eunice S Wang
Prevention, recognition, and management of adverse events associated with gemtuzumab ozogamicin use in acute myeloid leukemia. Journal of hematology & oncology 13 (1) (2020)
Preetesh Jain, Hagop Kantarjian, Prajwal C Boddu, Graciela Nogueras Gonzalez, Srdan Verstovsek, Guillermo Garcia-Manero, Gautam Borthakur, Koji Sasaki, Tapan M Kadia, Princy Sam, Hycienth Ahaneku, Susan O'Brien, Zeev Estrov, Farhad Ravandi, Elias Jabbour, Jorge E Cortes
Analysis of cardiovascular and arteriothrombotic adverse events in chronic-phase CML patients after frontline TKIs. Blood advances 3 (6) (2020)
Gautam Borthakur, Zhihong Zeng, Jorge E Cortes, Hsiang-Chun Chen, Xuelin Huang, Marina Y Konopleva, Farhad Ravandi, Tapan Mahendra Kadia, Keyur P Patel, Naval G Daver, Mary A Kelly, Teresa McQueen, Ru-Yiu Wang, Hagop M Kantarjian, Michael Andreeff
Phase 1 study of combinatorial sorafenib, G-CSF, and plerixafor treatment in relapsed/refractory, FLT3-ITD-mutated acute myelogenous leukemia patients. American journal of hematology 95 (11) (2020)
Musa Yilmaz, Hagop M Kantarjian, Gokce Toruner, C Cameron Yin, Rashmi Kanagal-Shamana, Jorge E Cortes, Ghayyas Issa, Nicholas J Short, Joseph D Khoury, Guillermo Garcia-Manero, Farhad Ravandi, Tapan Kadia, Marina Konopleva, William G Wierda, Nitin Jain, Zeev E Estrov, Koji Sasaki, Sherry Pierce, Susan M O'Brien, Elias J Jabbour
Translocation t(1;19)(q23;p13) in adult acute lymphoblastic leukemia - a distinct subtype with favorable prognosis. Leukemia & lymphoma 62 (1) (2020)
Koiji Sasaki, Elias J Jabbour, Farhad Ravandi, Marina Y Konopleva, Gautam Borthakur, William G Wierda, Naval G Daver, Koichi Takahashi, Kiran Naqvi, Courtney D D DiNardo, Guillermo Montalban Bravo, Rashmi Kanagal-Shamana, Ghayas Issa, Preetesh Jain, Jeffrey Skinner, Mary B Rios, Sherry Pierce, Kelly A Soltysiak, Junya Sato, Guillermo Garcia Manero, Jorge E Cortes
The LEukemia Artificial Intelligence Program (LEAP) in chronic myeloid leukemia in chronic phase: A model to improve patient outcomes. American journal of hematology 96 (2) (2020)
Anand P Jillella, Martha L Arellano, Manila Gaddh, Amelia A Langston, Leonard T Heffner, Elliott F Winton, Morgan L McLemore, Yuchen Zhang, Catherine R Caprara, Kathryn S Simon, Sheldon L Bolds, Stephanie DeBragga, Prachi Karkhanis, Shruthi H Krishnamurthy, Jose Tongol, Mohamed M El Geneidy, Asim Pati, Jonathan M Gerber, Michael R Grunwald, Jorge E Cortes, Asad Bashey, Robert K Stuart, Vamsi K Kota
Comanagement Strategy Between Academic Institutions and Community Practices to Reduce Induction Mortality in Acute Promyelocytic Leukemia. JCO oncology practice 17 (4) (2020)
Kiyomi Morita, Feng Wang, Katharina Jahn, Tianyuan Hu, Tomoyuki Tanaka, Yuya Sasaki, Jack Kuipers, Sanam Loghavi, Sa A Wang, Yuanqing Yan, Ken Furudate, Jairo Matthews, Latasha Little, Curtis Gumbs, Jianhua Zhang, Xingzhi Song, Erika Thompson, Keyur P Patel, Carlos E Bueso-Ramos, Courtney D D DiNardo, Farhad Ravandi, Elias Jabbour, Michael Andreeff, Jorge E Cortes, Kapil Bhalla, Guillermo Garcia Manero, Hagop Kantarjian, Marina Y Konopleva, Daisuke Nakada, Nicholas Navin, Niko Beerenwinkel, P Andrew Futreal, Koichi Takahashi
Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics. Nature communications 11 (1) (2020)
Ghayas C Issa, Hagop M Kantarjian, Lianchun Xiao, Jing Ning, Yesid Alvarado, Gautam Borthakur, Naval Daver, Courtney D DiNardo, Elias Jabbour, Prithviraj Bose, Nitin Jain, Tapan Mahendra Kadia, Kiran Naqvi, Naveen Pemmaraju, Koichi Takahashi, Srdan Verstovsek, Micheal Andreeff, Steven Mitchell Kornblau, Zeev Estrov, Alessandra Ferrajoli, Guillermo Garcia-Manero, Maro Ohanian, William G Wierda, Farhad Ravandi, Jorge E Cortes
Phase II trial of CPX-351 in patients with acute myeloid leukemia at high risk for induction mortality. Leukemia 34 (11) (2020)
Rita Assi, Hagop Kantarjian, Michael Keating, Naveen Pemmaraju, Srdan Verstovsek, Guillermo Garcia-Manero, Farhad Ravandi, Gautam Borthakur, Jenny Dahl, Elias Jabbour, Jorge E Cortes
Management of chronic myeloid leukemia during pregnancy among patients treated with a tyrosine kinase inhibitor: a single-Center experience. Leukemia & lymphoma 62 (4) (2020)
Jorge E Cortes, Anna Candoni, Richard E Clark, Brian Leber, Pau Montesinos, Paresh Vyas, Amer M Zeidan, Michael Heuser
Selection and management of older patients with acute myeloid leukemia treated with glasdegib plus low-dose cytarabine: expert panel review. Leukemia & lymphoma 61 (14) (2020)
Zimu Gong, Mina L Xu, Mingyi Chen, Wei Cui, Hagop M Kantarjian, Jorge E Cortes, Ting Zhou, Guillin Tang, Wei Wang, L Jeffrey Medeiros, Shimin Hu
Philadelphia chromosome-negative acute leukemia in patients with chronic myeloid leukemia. American journal of hematology 94 (10) (2019)
Jesus G Berdeja, Michael C Heinrich, Shaker R Dakhil, Stuart L Goldberg, Martha Wadleigh, Philip Kuriakose, Jorge E Cortes, Jerald Radich, Bret Helton, David A Rizzieri, Carole Paley, Ilva Dautaj, Michael J Mauro
Rates of deep molecular response by digital and conventional PCR with frontline nilotinib in newly diagnosed chronic myeloid leukemia: a landmark analysis. Leukemia & lymphoma 60 (10) (2019)
Paolo Strati, Guillermo Garcia-Manero, Chong Zhao, Tapan Mahendra Kadia, Gautam Borthakur, Marina Konopleva, Naval G Daver, Courtney D D DiNardo, Nicholas James Short, Musa Ylimaz, Kiran Naqvi, Yesid Alvarado, Sherry A Pierce, Jorge E Cortes, Carlos Bueso-Ramos, Hagop M Kantarjian, Farhad Ravandi
Intensive chemotherapy is more effective than hypomethylating agents for the treatment of younger patients with myelodysplastic syndrome and elevated bone marrow blasts. American journal of hematology 94 (7) (2019)
Musa Ylimaz, Hagop M Kantarjian, Xuemei Wang, Joseph D Khoury, Farhad Ravandi, Jeffrey Jorgensen, Nicholas James Short, Sanam Loghavi, Jorge E Cortes, Guillermo Garcia-Manero, Tapan Mahendra Kadia, Koji Sasaki, Marina Konopleva, Koichi Takahashi, William Wierda, Nitin Jain, Srdan Verstovsek, Zeev Estrov, Prithviraj Bose, Sherry Pierce, Rebecca Garris, Susan M O'Brien, Elias J Jabbour
The early achievement of measurable residual disease negativity in the treatment of adults with Philadelphia-negative B-cell acute lymphoblastic leukemia is a strong predictor for survival. American journal of hematology 95 (2) (2019)
Naveen Pemmaraju, Hagop M Kantarjian, Loretta J Nastoupil, Megan Dupuis, Lisa Zhou, Sherry Pierce, Keyur P Patel, Lucia Masarova, Jorge E Cortes, Srdan Verstovsek
Characteristics of patients with myeloproliferative neoplasms with lymphoma, with or without JAK inhibitor therapy. Blood 133 (21) (2019)

Jorge E Cortes.css-eqlu8i{font-size:small;padding-left:4px;} (Jorge Cortes)

Publication Activity (10 Years)

Top Topics

Top Venues

Jorge E Cortes (Jorge Cortes)